好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acetazolamide for treatment of drop attacks due to Symptomatic Plateau Waves: A case report
Neuro-oncology
(-)
211
Authors/Disclosures
Surabhi Ranjan, MD
PRESENTER
Dr. Ranjan has nothing to disclose.
David Schiff, MD, FAAN (Univ of VA, Division of Neuro Oncology) Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.
Eric Pearlman, MD Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.